Age-related macular degeneration is the most common cause of choroidal neovascularization (CNV) and it is an important cause of vision loss in the ageing population. CNV is a multifactorial condition whose pathogenesis involves inflammation, angiogenesis and fibrosis. All available monotherapies are directed specifically to only one part of the CNV process. Combination therapy may act simultaneously on different pathways in the pathogenesis of CNV, resulting in additive or synergistic effects that may help to achieve good treatment outcome with few treatments needed. Large controlled studies are needed to achieve the best combination therapy for CNV. © 2010 Expert Reviews Ltd.

Update on combination therapy in wet age-related macular degeneration

LANZETTA, Paolo;VERITTI, Daniele;SARAO, Valentina
2010-01-01

Abstract

Age-related macular degeneration is the most common cause of choroidal neovascularization (CNV) and it is an important cause of vision loss in the ageing population. CNV is a multifactorial condition whose pathogenesis involves inflammation, angiogenesis and fibrosis. All available monotherapies are directed specifically to only one part of the CNV process. Combination therapy may act simultaneously on different pathways in the pathogenesis of CNV, resulting in additive or synergistic effects that may help to achieve good treatment outcome with few treatments needed. Large controlled studies are needed to achieve the best combination therapy for CNV. © 2010 Expert Reviews Ltd.
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11390/1021151
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 2
  • ???jsp.display-item.citation.isi??? ND
social impact